How A Doctor Cured His Own Terminal Disease | Dr. David Fajgenbaum

Dr. David Fajgenbaum shares his remarkable personal journey of surviving a terminal diagnosis of Castleman's disease, a rare condition that killed him multiple times during his medical training. His story illustrates a powerful but underutilized principle in medicine: many FDA-approved drugs can successfully treat diseases entirely different from their original indication. Rather than accepting his death sentence, Fajgenbaum took an active role in his own treatment, systematically exploring whether medications approved for other conditions might help his disease. This approach led him to discover that sirolimus, a drug typically used for organ transplant rejection, effectively treated his condition when traditional approaches had failed. The episode explores the science behind why this works, focusing on the concept of cytokine storms, where the immune system overreacts and causes widespread inflammation and tissue damage. Many seemingly unrelated diseases actually involve similar immune dysregulation, meaning treatments developed for one condition might address the underlying mechanism in another. Fajgenbaum founded Every Cure, an initiative dedicated to identifying existing approved drugs that could treat currently incurable diseases. Rather than waiting years for new drug development, his organization systematically tests whether compounds already vetted for safety might address other medical conditions. This approach has tremendous potential for rare diseases and cancers where patient populations are too small to justify traditional drug development pipelines. The conversation delves into how mindset plays a crucial role in fighting disease. Fajgenbaum emphasizes that maintaining agency, hope, and active participation in medical decision-making appears to influence outcomes in ways that go beyond placebo effects. He discusses the importance of educating yourself about your condition and working collaboratively with physicians rather than passively accepting medical authority. The episode also touches on how insights from immunology and inflammation can inform strategies for health and longevity in otherwise healthy individuals. Understanding how to modulate immune activation and prevent chronic inflammatory states has applications beyond treating rare diseases. Fajgenbaum's work demonstrates that the divide between treatable and untreatable diseases may be more permeable than the medical establishment typically acknowledges. His scientific rigor combined with personal determination creates a compelling case for how patients, researchers, and physicians can challenge conventional wisdom and discover life-saving treatments hiding in plain sight within our existing pharmaceutical arsenal. The episode provides both inspiration and practical frameworks for thinking differently about medical challenges.